Tipping the scales: Immunotherapeutic strategies that disrupt immunosuppression and promote immune activation.

Santiago-Sánchez, Ginette S; Hodge, James W; Fabian, Kellsye P

Santiago-Sánchez, Ginette S; Hodge, James W; Fabian, Kellsye P.

Afiliação

Santiago-Sánchez GS; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Hodge JW; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Fabian KP; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.

Front Immunol ; 13: 993624, 2022.

Article em En | MEDLINE | ID: mdl-36159809

Assuntos

Vacinas Anticâncer; Neoplasias; Antígenos de Neoplasias; Humanos; Inibidores de Checkpoint Imunológico; Terapia de Imunossupressão; Imunoterapia/métodos; Fator de Crescimento Transformador beta; Microambiente Tumoral

Palavras-chave

NC410; bintrafusp alfa; checkpoint blockade; costimulatory receptors; immunocytokine; immunosuppression; vaccines

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas Anticâncer / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas Anticâncer / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article